Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03012139 · ClinicalTrials.gov registry record

Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
31
Enrollment target

NCT03012139: Completed study, sponsored by Mayo Clinic.

NCT03012139 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03012139 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
31 participants
Enrollment target

Study Summary

This study is designed to gain a better understanding of the mechanisms leading to muscle wasting and metabolic abnormalities in skeletal muscle of cancer patients.

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2017-01
Est. Completion 2019-10-11

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT03012139

The ClinicalTrials.gov registry entry for NCT03012139 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03012139 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03012139 about?

NCT03012139 is a clinical study titled "Cancer-Associated Muscle Atrophy and Weakness: An Investigation of Etiology". This study is designed to gain a better understanding of the mechanisms leading to muscle wasting and metabolic abnormalities in skeletal muscle of cancer patients.

What is the current status of trial NCT03012139?

This trial is currently completed. The enrollment target is 31 participants. The study started on 2017-01. Estimated completion is 2019-10-11.

Who is sponsoring clinical trial NCT03012139?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.